Metabolic Health
What Happens to Your Cholesterol When You Stop Drinking
A massive Japanese cohort study tracked the exact moments adults quit — or started — drinking, and watched their LDL and HDL move in opposite directions.
Metabolic Health
Depth reporting on blood sugar, insulin sensitivity, body composition, and the metabolic drivers of chronic disease risk.
Metabolic Health
Eat Less, Eat Later: What New Research on Caloric Restriction and Time-Restricted Eating Means for the Aging Heart
Two 2025 papers connect how we eat — and when — to the metabolic stress pathways behind a stubborn form of heart failure. The science is promising, the certainty is not.
Metabolic Health
The Muscle Question: What Sarcopenic Obesity and Diabetes Drugs Mean for Aging Well
Two new studies reframe the conversation around metabolic health in later life — pointing to skeletal muscle, mitochondria, and medication choice as the quiet variables that matter.
Metabolic Health
Obesity as an Accelerator of Cardiovascular Aging — And Why Weight Loss May Buy You Time
A major European Heart Journal review reframes excess weight as a driver of the heart's biological aging itself. The implication: weight reduction may be less about preventing one bad day and more about extending healthy years.
Metabolic Health
Plant-Forward Eating, Reviewed: What 32 Long-Term Studies Actually Show
A 2025 systematic review maps where plant-based eating moves the metabolic needle — and where the evidence still thins out. Here's what a busy 40-year-old should actually take from it.
Metabolic Health
GLP-1s Beyond Weight Loss: Kidneys, Taste Buds, and What the Real-World Data Actually Show
A multinational cohort sketches who's really starting GLP-1s for diabetes and kidney disease — and a new mouse study hints these drugs may rewire taste itself.
Metabolic Health
GLP-1s Without Diabetes: New Surgical Data Complicates the 'Weight-Loss Only' Story
A retrospective hip-replacement study suggests non-diabetic GLP-1 users may not face the malnutrition penalty surgeons feared — but the questions are bigger than one paper.
Metabolic Health
Beyond Weight Loss: What the Latest GLP-1 Evidence Says About Liver, Kidney, Heart, and Cost
Fresh 2025 reviews map semaglutide's reach into fatty liver disease, cardiovascular risk, kidney protection — and the economics of treating obesity at scale. The signals are real, but the picture is still filling in.
Metabolic Health
GLP-1s Grow Up: What the Latest Research Says About Weight Regain, Brain Health, and Your Eyes
A cluster of new 2025 papers reframes GLP-1 drugs as long-horizon metabolic tools — with real promise after bariatric surgery, a tantalizing brain-protection signal, and one safety question worth taking seriously.
Metabolic Health
Beyond Semaglutide: The Next Wave of GLP-1 Drugs Targets the Heart, Kidneys, and Joints
The shots that started as diabetes medicine and became weight-loss icons are quietly rewriting their own job description. The 2025 evidence points to a multi-organ story — with caveats worth knowing.